Navigation Links
Medbox, Inc. Announces Top-Tier Rating by Dun & Bradstreet Credibility Corporation
Date:5/9/2012

HOLLYWOOD, Calif., May 9, 2012 /PRNewswire/ -- Medbox, Inc. (Pinksheets: MDBX) (www.medboxinc.com) announced today that the company, through its wholly owned Subsidiary, Prescription Vending Machines, Inc., has upgraded its credit worthiness and corporate stability ratings to top tier status with Dun & Bradstreet Credibility Corp.  Dun & Bradstreet is a company that is steeped in tradition, woven into the fiber of corporate America in the credit reporting industry, dating back to 1837.

D&B's proprietary set of key ratings include the PAYDEX® Score, a predictive indicator for paying bills on time; the Financial Stress Score, an indicator of financial stress in the next 12 months; and the Credit Limit Recommendation, which provides guidelines for extending business credit and an overall D&B Rating which addresses the overall assessment of a business.

Medbox, Inc. (DUNS: 93-072-9434) ranked in the top two tiers in every one of the criteria listed above as well as in the 87th percentile in commercial credit score as compared to other businesses nationally.

"With the posting of our latest financials and the recent top-tier rating by D&B, we are setting the stage for what is proving to be our most successful year ever," stated Dr. Bruce Bedrick, CEO of Medbox, Inc.

About Medbox, Inc: 

Medbox is a leader in the development, sales and service of automated, biometrically controlled dispensing and storage systems for medicine and merchandise. Medbox has offices throughout the world, including New York, Tokyo and Toronto, and has their corporate headquarters in Los Angeles.

Medbox provides their patented systems, software and consulting services to pharmacies, urgent care centers, clinics, hospitals, and medical groups worldwide.

Medbox, Inc. is a publicly traded company, and is listed on the OTC Board, ticker symbol MDBX.

For more information on Medbox, please contact the Medbox Investor Relations Department at (800) 762-1452 or go online to www.medboxinc.com.

 


'/>"/>
SOURCE Medbox, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology news :

1. Medbox, Inc. Announces New Board of Directors After Acquisition of Prescription Vending Machines, Inc.
2. Medbox, Inc. Announces Approval in Colorado House Bill (HB1043)
3. Medbox, Inc. Announces New Product Line for 2012
4. NIAID announces 25 new awards to develop radiation countermeasures
5. Aware Announces Q3 2008 Earnings Conference Call
6. Governor Doyle announces historic genomic research collaboration
7. BIO-key(R) Announces Additional $245,000 in Third Quarter Public Safety Orders
8. NARSAD announces 2008 Prizes for Outstanding Achievement in Research on Mental Health Disorders
9. Parkinsons Disease Foundation announces award of $150,000
10. Jefferson Department of Surgery announces new pancreas tumor registry
11. NAS announces initiative to connect entertainment industry with top experts
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/6/2017)... 2017  Delta ID Inc., a leader in consumer-grade ... automotive at CES® 2017. Delta ID has collaborated with ... the use of iris scanning as a secure, reliable ... in a car, and as a way to elevate ... Delta ID and Gentex will demonstrate (booth #7326 ...
(Date:12/22/2016)... Dec. 20, 2016  As part of its longstanding mission ... personal genetics company, recently released its latest children,s book, titled ... book focuses on the topics of inheritance and variation of ... (NGSS) taught in elementary school classrooms in the US. ... by illustrator Ariana Killoran , whose previous book with ...
(Date:12/19/2016)... España y TORONTO , 19 de diciembre de ... Biologics Inc. que permitirá el desarrollo acelerado de MSC-1, un anticuerpo ... varios tipos de tumor en 2017, con múltiples sitios previstos a ... ... con objetivo en el factor inhibidor de leucemia (LIF), una citoquina ...
Breaking Biology News(10 mins):
(Date:1/19/2017)... SHANGHAI , Jan. 19, 2017 /PRNewswire -- ... medical device open-access capability and technology platform, today ... a leading biology focused preclinical drug discovery contract ... Biosciences will become a wholly-owned subsidiary of WuXi, ... core competences and providing greater services. The acquisition ...
(Date:1/19/2017)... , Jan. 19, 2017  ArmaGen, Inc., today ... , Ph.D., as chief executive officer, as well ... Dr. Schmidt brings to ArmaGen more than 17 years ... and development of biotherapeutics and pharmaceuticals. ... the diverse experience and skillset necessary to lead ...
(Date:1/19/2017)... Minneapolis, Minnesota (PRWEB) , ... January 19, 2017 ... ... contract research organization with services spanning the full spectrum of drug and device ... clinical research services to pharma/device companies and clinicians, today announced Verified Clinical ...
(Date:1/18/2017)... , ... January 18, 2017 , ... ... essential device-to-computer interconnect using USB or PCI Express, announced the ZEM5310 USB 3.0 ... E FPGA into a compact business-card sized form factor suitable for prototyping, testing, ...
Breaking Biology Technology: